Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
Variability in non-nucleoside reverse transcriptase and protease inhibitor concentrations among HIV-infected adults in routine clinical practice.
Viral failure in HIV-infected patients with long-lasting viral suppression who discontinued enfuvirtide.
Inhibition of HIV-1 replication by RNA interference of p53 expression.
3'-Azido-2',3'-dideoxythymidine (zidovudine) uptake mechanisms in T lymphocytes.
Treatment of monocytes with interleukin (IL)-12 plus IL-18 stimulates survival, differentiation and the production of CXC chemokine ligands (CXCL)8, CXCL9 and CXCL10.
The effect of atorvastatin treatment on HIV-1-infected patients interrupting antiretroviral therapy.
Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs.
Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins.
Update of the drug resistance mutations in HIV-1: Fall 2006.
Increased antiretroviral potency by the addition of enfuvirtide to a four-drug regimen in antiretroviral-naive, HIV-infected patients.